Albumin and Protein Oxidation are Predictors that Differentiate Relapsing-Remitting from Progressive Clinical Forms of Multiple Sclerosis

Sayonara Rangel Oliveira; Ana Paula Kallaur; Edna Maria Vissoci Reiche; Damacio Ramón Kaimen-Maciel; Carolina Panis; Marcell Alysson Batisti Lozovoy; Helena Kaminami Morimoto; Michael Maes; Isaías Dichi; Andréa Name Colado Simão

doi:10.1007/s12035-016-9860-z

Related publications

Article2005

Progressive Gray Matter Damage in Patients With Relapsing-Remitting Multiple Sclerosis

Celia Oreja‐Guevara, Marco Rovaris, Giuseppe Iannucci, Paola Valsasina, Domenico Caputo, Rosella Cavarretta, Maria Pia Sormani, Pasquale Ferrante, Giancarlo Comi, Massimo Filippi

Article1999

Long-term changes of magnetization transfer-derived measures from patients with relapsing-remitting and secondary progressive multiple sclerosis.

Maria A. Rocca, G. Mastronardo, Mariemma Rodegher, Giancarlo Comi, Massimo Filippi

Article2023

Pain and participation in social activities in people with relapsing remitting and progressive multiple sclerosis

Dhruv Jain, Çharles N. Bernstein, Lesley A. Graff, Scott Burton Patten, James M. Bolton, John D. Fisk, Carol Hitchon, James Marriott, Ruth Ann Marrie

Article2014

Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis

Per Soelberg Sørensen, Steen Lisby, Richard Grove, Frederick J. Derosier, Steve Shackelford, Eva Havrdová, Jelena Drulović, Massimo Filippi

Article2017

Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients with Very Mild Clinical Disability

Simone Migliore, Anna Ghazaryan, Ilaria Simonelli, Patrizio Pasqualetti, Ferdinando Squitieri, Giuseppe Curcio, Doriana Landi, Maria Giuseppina Palmieri, Filomena Moffa, Massimo Filippi, Fabrizio Vernieri